pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 8·1 min read
save

Trump administration seeks lasting overhaul of federal science policy after court setbacks

Jul 8, 2026·read at STAT ↗RegulatoryNegative

The White House has introduced a proposal to cement its authority over federal research contracts, allowing the executive branch to direct research, end grants, and control external scientific reviews.

The move follows a series of actions in the first year of the Trump administration that included firing many federal civil servants, terminating numerous research projects, and pressuring universities to drop diversity initiatives, many of which were quickly challenged in court under the Administrative Procedures Act.

Legal challenges forced the administration to retreat on several policies, but the new Office of Management and Budget proposal aims to make the changes more durable, according to experts who say future administrations could still revert them.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump administration pursues more durable changes to science policy after setbacks in court”

read at STAT ↗
499 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoSTAT+: Seattle scientists launch $95 million AI biology effortSTAT
  • 2h agoSTAT+: Fauci speaks, and writesSTAT
  • 3h agoHHS flip-flops on disability lawsuitSTAT
  • 3h agoSTAT+: OpenEvidence launches new family of AI modelsSTAT
  • 3h agoSTAT+: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and moreSTAT